BA

Bruce A. Peacock

North America, Maryland, United States, Baltimore

Description

Bruce Peacock joined Ophthotech in September 2010 as the Chief Business Officer. Bruce Peacock brings a wealth of business development and l...

Investor Profile

Bruce A. Peacock has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Seed (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Bruce A. Peacock frequently co-invest with?

The Mark Foundation for Cancer Research
North America, New York, United States, New York
Co-Investments: 1
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Tellus BioVentures
North America, New York, United States, Florida
Co-Investments: 1
Penn Medicine Co-Investment Program
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1

What are some of recent deals done by Bruce A. Peacock?

Interius BioTherapeutics

Philadelphia, Pennsylvania, United States

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

BiopharmaBiotechnologyHealth CareTherapeutics
SeedMar 13, 2020
Amount Raised: $5,500,000